Is a urine urobilinogen level of 133 μmol/L severe?
Oct 09, 2023
Source: Cainiu Health
Dr. Zhang Cong
Introduction
A urinary urobilinogen level of 133 μmol/L indicates a relatively serious condition. Elevated urobilinogen may result from physiological factors, hemolytic jaundice, hepatocellular jaundice, obstructive jaundice, bile duct obstruction, or diseases such as cardiac insufficiency and congestive heart failure. Without a clear diagnosis, patients are advised to seek timely medical attention and receive appropriate treatment to avoid delaying the management of their condition.
Under normal circumstances, urobilinogen is one of the parameters tested in a routine urinalysis. The reference range is typically 0.30–3.55 μmol/L for males, 0.00–2.64 μmol/L for females, and 0.13–2.30 μmol/L for children. A value reaching 133 μmol/L indicates a relatively severe condition. Causes of elevated urobilinogen mainly include physiological factors, hemolytic jaundice, hepatocellular jaundice, obstructive jaundice, and bile duct obstruction. Specific details are as follows:
1. Physiological factors
Urobilinogen refers to the presence of a certain amount of bilirubin in urine. If the elevation is caused by physiological factors such as prolonged fasting or intense physical exercise, special treatment is generally not required, as the body can self-regulate.
2. Hemolytic jaundice
When a large number of red blood cells are destroyed or hemolysis occurs, patients may develop anemia and hypoxia. This also reduces the liver cells' ability to metabolize bilirubin, leading to increased urobilinogen levels. Patients are advised to follow medical guidance and use medications such as dexamethasone acetate tablets or hydrocortisone tablets for treatment.
3. Hepatocellular jaundice
Severe liver damage impairs bilirubin circulation in the body, potentially causing elevated urobilinogen. This condition is commonly seen in diseases such as viral hepatitis, liver abscesses, and cirrhosis. In such cases, patients may take medications like glutathione tablets or ursodeoxycholic acid tablets as directed by their physician.
4. Obstructive jaundice
When bilirubin cannot enter the intestines due to obstruction, it enters the bloodstream and is excreted via urine, resulting in increased urobilinogen levels. This is commonly associated with conditions such as gallstones, parasitic infections, or tumors. Patients may take prescribed medications such as anti-inflammatory and bile-promoting tablets or ursodeoxycholic acid capsules. Additionally, bile drainage procedures may be performed to restore patency of the biliary tract.
5. Bile duct obstruction
When bile duct obstruction occurs, bile cannot be properly excreted from the body, leading to progressively increased bilirubin levels in the blood and subsequently elevated urobilinogen. Patients may take medications such as anti-inflammatory and bile-promoting tablets or cefixime dispersible tablets under medical supervision. Alternatively, surgical interventions such as choledochojejunostomy or hepatectomy may be performed under a doctor's guidance.
In addition, a urobilinogen level of 133 μmol/L may also be caused by conditions such as heart failure or congestive heart failure. If the underlying cause remains unclear, patients are advised to seek timely medical evaluation and receive appropriate treatment to avoid disease progression.
